EuroSciCon Congress on

Obesity and Diabetes

Theme: Emphasizing latest Innovations in the field of Obesity & Diabetes

Event Date & Time

Event Location

Athens, Greece

16 years of lifescience communication

Performers / Professionals From Around The Globe

Tracks & Key Topics

Obesity and Diabetes 2018

ABOUT CONFERENCE

About Conference

EuroSciCon proudly announces the conference on “Congress on Obesity and Diabetes 2018” during November 12-13, 2018 Athens, Greece, with the theme “Emphasizing latest Innovations in the field of Obesity & Diabetes”. EuroSciCon through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.

This year Obesity and Diabetes 2018 is bringing a special session focusing the two major problems of today’s world those are accompanied not only with the health issues, but also the food value and financial importance.

Scope and Importance

This gathering will bear some significance with anybody frightened in getting the hang of, sharing issues and encounters regarding Obesity and Diabetes and their related areas of Medicine and Health Care.

Who Can Attend?

This conference gets driving and experienced Metabolic and Bariatric Surgeons, Physicians, Basic and Clinical Research Scientists, Integrated Health Professionals, Registered Dieticians and Diabetes Educators, Physical Therapists, Students, Industry Professionals, Fitness Professionals and Health Promoters and some more.

Why to Attend?

With associates from around the world focused on learning about obesity and diabetes their effects, this is your best chance to reach the largest assemblage of participants. It will be an excellent opportunity as it will be the most cost-effective professional development choice. It will be the most relevant and densely-packed educational and networking opportunity focused on Obesity Research, obesity issues available to professionals nationwide, Diabetes Disorders and its advances in making a better health.  Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in obesity and nutrition are hallmarks of this conference.

Why Athens, Greece?

Athens is the capital and one of the major city of Greece. Athens leads the Attica region and is one of the world's oldest cities. Athens is a universal city and one of the prime economic centres in southeaster Europe. It has a large financial sector, and its port Piraeus is both the largest passenger port in Europe, and the second largest in the world. Athens stretches across the middle of Attica that is often referred to as the Athens or Attica Basin. The municipality of Athens is the maximum populous in Greece, with a population of 664,046 people and an area of 38.96 km2, forming the core of the Athens Urban Area within the Attica Basin. Athens incorporates architectural styles ranging from Greco-Roman and Neoclassical to modern times. Athens has been a destination for travellers since olden days. There are 148 theatrical stages in Athens, in any other city in the globe, with the ancient Odeon of Herodes Atticus, home to the Athens Festival, which runs from May to October each year. Athens is serviced by a variety of transport means, forming the largest mass transit system of Greece.

SESSION TRACKS

Track 1: Obesity

Obesity is characterized as overabundance of fat tissue. There are a few distinct strategies for deciding overabundance tissue; generally known is the Body Mass Index (BMI). In that capacity, fat tissue secretes various items, including metabolites, cytokines, lipids, and coagulation elements among others. Effective weight reduction medicines incorporate setting objectives and rolling out way of life improvements.

  • Obesity

  • Body Mass Index

  • Pharmaceutical Reduction

  • Weight Reduction

 

Track 2: Diabetes

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycaemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels.

  • Diabetes
  • Metabolic Disease
  • Novel Paradigms
  • Diabetic Complications

Track 3: Obesity and Associated Health Disorders

Obesity is characterized by the excessive deposition of fat in the adipose tissue. Its consequences go far beyond adverse metabolic effects on health such as increase in oxidative stress, which leads not only to endothelial dysfunction but also to negative effects in relation to periodontitis, because of the increase in Proinflammatory cytokines.

  • Osteoarthritis
  • Gallbladder Disorders
  • Sleep Apnoea
  • Gout

Track 4: Obesity and Cardiac Issues

Obesity is becoming a major complication in recent times. It is associated with numerous comorbidities such as Cardiovascular diseases, type 2 diabetes, hypertension, Breast cancers, and sleep apnoea/sleep-disordered breathing. Other important element of obesity is that, it is the only independent risk factor for CVD, and it is also documented in obese children.

  • Atherosclerosis
  • Osteoarthritis
  • Salt and Obesity
  • Mental Illness

Track 5: Treatment of Obesity

The goal of obesity treatment is to reach and stay at a healthy weight. It needs to work with a team of health professionals including a dietician, behaviour counsellor or an obesity specialist to help and make changes in your eating and activity habits. All weight-loss programs require change in eating habits and increased physical activity. The treatment methods that are right for you depend on level of obesity, overall health and your willingness to participate in your weight-loss plan.

  • Behavioural Therapy
  • Bariatric Surgery
  • Personality Development
  • Dietary Modification

Track 6: Anti- Obese Drugs

Anti-obesity medication are all Pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.

  • Herbal Drugs
  • Phytoplankton
  • Microbes
  • Synthetic Drugs

Track 7: Genetic Obesity

Genes can directly cause obesity. Obesity is a complex disease resulting from the interactions of a wide variety of hereditary and environmental factors. The combined progress in quantitative genetics, genomics and bioinformatics has contributed to a better understanding of the genetic and molecular basis of obesity.

  • Epigenetics
  • Hereditary Factors
  • Clinical Genomics
  • Nutrigenetics

Track 8: Childhood Obesity

Paediatric obesity is becoming the complex issue in the recent times. It is noticed when a child is above normal weight respective to their height and BMI. The main cause for this is due to behavioural change or by genetics. Obesity now affects one in five children in the United States. Discrimination against overweight children begins early in childhood and becomes progressively institutionalized.

  • Paediatric Obesity
  • Depression
  • Kinesiology
  • Endocrine Disorders

Track 9: Endocrinal Obesity

Obesity is associated with several endocrine diseases. The mechanisms for the development of obesity vary in according to the endocrine condition. Hypothyroidism is associated with accumulation of hyaluronic acid within various tissues, additional fluid retention due to reduced cardiac output and reduced thermogenesis. The pathophysiology of obesity associated with Polycystic Ovarian Syndrome remains complex as obesity, itself may simultaneously be the cause.

  • Cushing Syndrome
  • Brain Trauma
  • Insulinoma
  • Endocrine Psychiatry

Track 10: Diabetes Melitus

It is a type of diabetes that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of insulin prompts expanded glucose in the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction.

  • Immune System
  • Annihilation
  • Type 1 Diabetes
  • Type 2 Diabetes

Track 11: Diabetes Chronic Complication

The term diabetes describes many diseases of abnormal super molecule metabolism that square measure characterized by hyperglycaemia. It is related to a relative impairment in endocrine secretion. They are derived once doing several clinical trials on animal models.

  • Hyperglycaemia
  • Endocrine
  • Glycosylated Haemoglobin
  • Plasma Aldohexose

Track 12: Biomarkers for Diabetes

Molecular Biomarkers is demarcated as a characteristic that is accurately measured associate in Nursing gauged as a pointer of traditional biological procedures, infective procedures. Biomarkers play Associate in Nursing very important half in leading clinical trials and treating patients. Advances in molecular medical specialty facilitate medical professionals create knowledgeable, scientifically valid selections.

  • Molecular Biomarkers
  • Molecular Medical Specialty
  • Biomarkers
  • Pathological Process

Track 13: Diabetes Research

Diabetes may be a common chronic illness that imposes right smart demands on the individual tending system. Diabetic dyslipidaemia is one among the foremost risk factors for disorder in diabetes. The characteristic options of diabetic dyslipidaemia are a high plasma lipid concentration, low cholesterol concentration and multiplied concentration of tiny dense LDL-cholesterol particles. So, as analysis to analyse the bioinformatics tools and methodologies accustomed in polygenic disease research, at first, this was tough to try and do as a result of it failed to have a preconceived notion concerning however the analysis would be organized and the way bioinformatics tools would be delineated or known within the analysis.

  • Renal Disorders
  • Dyslipidaemia
  • Cholesterol
  • Bioinformatics

Track 14: Genetics of Diabetes

Several factors must come together for a person to develop type 2 diabetes. However, type 2 diabetes also has a strong genetic component. Diabetes constitutes a major public health problem. The burden of diabetes is much higher for racial/ethnic minorities than for whites. This has significantly improved our knowledge of one of the most serious health threats in the world, allowing identification of genes and pathways involved in the development and progression of the disease. It has recently become possible to acquire molecular and genetic level information from an individual.

  • Prognostic Biomarkers
  • Nephropathy
  • Albuminuria
  • Inflammatory Markers

Track 15: Obesity and Diabetes

Most patients with type 2 diabetes are obese, and the global epidemic of obesity largely explains the dramatic increase in the incidence and prevalence of Type 2 diabetes over the past 20 years. Excess weight is an established risk factor for type 2 diabetes, yet most obese individuals do not develop type 2 diabetes. Recent studies have identified links between obesity and type 2 diabetes involving Pro inflammatory cytokines, Insulin resistance, deranged fatty acid metabolism, and cellular processes such as Mitochondrial dysfunction and endoplasmic reticulum stress.

  • Nutritional Therapy
  • Hyperinsulinism
  • Obesity dependent Diabetes treatment
  • Normal Insulin Sensitivity

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!